Crispr Therapeutics pares loss amid takeover speculation

• Crispr Therapeutics (CRSP) pared a loss amid some takeover speculation.
• There's speculation that a takeover bid for Crispr (CRSP) could be moving along as the potential buyer has hired an adviser to help with a bid, according to traders, who cited a Betaville "uncooked" alert that was circulating on Monday. People following the matter have heard talk that the potential bidder may have hired law firm Skadden for a takeover. 
• The latest update comes after Betaville last month said a US-based biopharma with a market cap of $100-$200 billion  may be interested in bidding for Crispr (CRSP). 

https://www.msn.com/en-us/money/companies/crispr-therapeutics-pares-loss-amid-takeover-speculation/ar-AA1Rv2gk